MX340231B - Enzimas fluidas incubadas y usos de las mismas. - Google Patents

Enzimas fluidas incubadas y usos de las mismas.

Info

Publication number
MX340231B
MX340231B MX2012006090A MX2012006090A MX340231B MX 340231 B MX340231 B MX 340231B MX 2012006090 A MX2012006090 A MX 2012006090A MX 2012006090 A MX2012006090 A MX 2012006090A MX 340231 B MX340231 B MX 340231B
Authority
MX
Mexico
Prior art keywords
skin
hatching fluid
nucleic acid
polypeptides
enzymes
Prior art date
Application number
MX2012006090A
Other languages
English (en)
Other versions
MX2012006090A (es
Inventor
Kristian Leren Hans
Th Walther Bernt
Original Assignee
Aqua Bio Tech Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41572950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX340231(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aqua Bio Tech Asa filed Critical Aqua Bio Tech Asa
Publication of MX2012006090A publication Critical patent/MX2012006090A/es
Publication of MX340231B publication Critical patent/MX340231B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24066—Choriolysin L (3.4.24.66)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica o cosmética caracterizada porque comprende: (i) un polipéptido que comprende una secuencia de aminoácidos como se expone en SEQ ID NO. 1: o (ii) un polipéptido que comprende una secuencia de aminoácidos que es al menos 70% idéntica a una región comparable de una secuencia de aminoácidos como se expone en SEQ ID NO: 1; o (iii) un polipéptido que comprende una porción de una secuencia de aminoácidos como se expone en SEQ ID NO. 1, en donde la porción comprende al menos 150 aminoácidos; o (iv) un polipéptido que comprende una porción de una secuencia de aminoácidos que es al menos 70% idéntica a una región comparable de una secuencia de aminoácidos como se establece en SEQ ID NO.1, en donde la porción comprende al menos 150 aminoácidos; y/o (v) una o más moléculas de ácido nucleico que codifican para un polipéptido como se expone a una cualquiera de (i) a (iv), o una secuencia complementaria de la misma, y uno o más excipientes y/o diluyentes farmacéuticamente o cosméticamente aceptables cuando se usan en terapia cosmética o médica.
MX2012006090A 2009-11-30 2010-11-30 Enzimas fluidas incubadas y usos de las mismas. MX340231B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0921001A GB0921001D0 (en) 2009-11-30 2009-11-30 Products and uses
PCT/EP2010/068509 WO2011064384A1 (en) 2009-11-30 2010-11-30 Hatching fluid enzymes and uses thereof

Publications (2)

Publication Number Publication Date
MX2012006090A MX2012006090A (es) 2012-09-07
MX340231B true MX340231B (es) 2016-07-01

Family

ID=41572950

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006090A MX340231B (es) 2009-11-30 2010-11-30 Enzimas fluidas incubadas y usos de las mismas.

Country Status (17)

Country Link
US (3) US9133256B2 (es)
EP (1) EP2506825B2 (es)
JP (1) JP5913117B2 (es)
KR (1) KR101842521B1 (es)
CN (2) CN104436163B (es)
AU (2) AU2010323022B2 (es)
CA (1) CA2781834C (es)
CL (1) CL2012001380A1 (es)
ES (1) ES2741586T5 (es)
GB (1) GB0921001D0 (es)
IN (1) IN2012DN04918A (es)
MX (1) MX340231B (es)
NZ (2) NZ600499A (es)
PL (1) PL2506825T5 (es)
RU (1) RU2595399C2 (es)
WO (1) WO2011064384A1 (es)
ZA (1) ZA201204066B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201110777D0 (en) * 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110783D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
PL2800737T3 (pl) * 2012-01-06 2020-11-02 Novus International Inc. Środki powierzchniowo czynne na bazie sulfotlenku
EP2691069B1 (en) * 2012-01-23 2016-09-28 Restorsea, LLC Cosmetic
KR102134938B1 (ko) * 2012-12-21 2020-07-17 아쿠아 바이오 테크놀로지 에이에스에이 어류 부화액으로부터의 화장료 조성물
GB201223330D0 (en) * 2012-12-21 2013-02-06 Aqua Bio Technology Asa Products, methods and uses
KR101505294B1 (ko) * 2013-06-19 2015-03-23 강릉원주대학교산학협력단 켈로이드 또는 흉터 형성을 감소시키기 위한 조성물
JP6089152B2 (ja) 2013-12-13 2017-03-01 レスターシー エルエルシイＲｅｓｔｏｒｓｅａ， Ｌｌｃ 剥脱性の毛髪保持促進製剤
AU2015259509A1 (en) 2014-05-16 2016-11-24 Restorsea, Llc Biphasic cosmetic
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions
CA3146128A1 (en) * 2019-07-05 2021-01-14 Regenics As Wound debridement systems
CN110592054B (zh) * 2019-08-29 2021-02-12 中国科学院南海海洋研究所 海马孵化酶基因及其编码蛋白和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3393559B2 (ja) * 1993-10-15 2003-04-07 株式会社ノエビア 皮膚外用剤
FR2743723B1 (fr) 1996-01-18 1998-04-17 Texinfine Sa Utilisation d'extrait des plantes de la famille des dictyotales en vue de la realisation de preparations destinees a remanier les elements glycosyles de la matrice extracellulaire de tissus vivants
NO314594B1 (no) 1997-12-11 2003-04-14 Aqua Bio Technology As Ikke-selvdegraderende endoprotease, fremgangsmåte for fremstilling samt anvendelser av denne
JP2002516670A (ja) 1998-05-27 2002-06-11 ラウラス エイエス Ｐｋａシグナリング経路のタンパク質活性を変化させる方法
FR2792202B1 (fr) 1999-04-19 2003-06-13 Pharmascience Lab Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
JP4643800B2 (ja) 2000-06-16 2011-03-02 エム・ディジャパン株式会社 プロテアーゼ阻害剤
JP2004529623A (ja) * 2001-02-20 2004-09-30 レキシコン・ジェネティクス・インコーポレーテッド 新規プロテアーゼおよびそれをコードするポリヌクレオチド
US20050074865A1 (en) † 2002-08-27 2005-04-07 Compound Therapeutics, Inc. Adzymes and uses thereof
GB0230006D0 (en) 2002-12-23 2003-01-29 Ares Trading Sa Proteins
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
WO2005046709A2 (en) * 2003-11-06 2005-05-26 Genencor International, Inc. Tgf - beta binding and supported peptides
CA2545053C (en) 2003-11-06 2016-04-19 Genencor International, Inc. Expression in filamentous fungi of protease inhibitors and variants thereof
WO2006088945A2 (en) * 2005-02-14 2006-08-24 The Regents Of The University Of California Granulysin peptides and methods of use thereof
JP2008094726A (ja) 2006-10-06 2008-04-24 Towa Koso Kk マイクロバブル洗浄用組成物、マイクロバブル洗浄方法及びマイクロバブル洗浄装置

Also Published As

Publication number Publication date
US20160053249A1 (en) 2016-02-25
AU2015202010B2 (en) 2017-04-20
US9133256B2 (en) 2015-09-15
IN2012DN04918A (es) 2015-09-25
BR112012012909A2 (pt) 2017-04-18
CN104436163A (zh) 2015-03-25
US20170189478A1 (en) 2017-07-06
CN102724954B (zh) 2018-07-27
KR20120115291A (ko) 2012-10-17
US9950031B2 (en) 2018-04-24
PL2506825T5 (pl) 2023-07-10
KR101842521B1 (ko) 2018-03-27
JP5913117B2 (ja) 2016-04-27
EP2506825B1 (en) 2019-05-08
JP2013511971A (ja) 2013-04-11
RU2595399C2 (ru) 2016-08-27
CA2781834A1 (en) 2011-06-03
US20120309689A1 (en) 2012-12-06
EP2506825A1 (en) 2012-10-10
PL2506825T3 (pl) 2019-11-29
CL2012001380A1 (es) 2012-11-30
GB0921001D0 (en) 2010-01-13
ES2741586T3 (es) 2020-02-11
NZ600499A (en) 2014-09-26
ES2741586T5 (es) 2023-08-18
AU2010323022B2 (en) 2015-05-14
NZ627941A (en) 2015-01-30
CN102724954A (zh) 2012-10-10
CA2781834C (en) 2019-02-12
AU2015202010A1 (en) 2015-05-14
AU2010323022A1 (en) 2012-06-21
MX2012006090A (es) 2012-09-07
US9624483B2 (en) 2017-04-18
EP2506825B2 (en) 2023-05-31
ZA201204066B (en) 2013-08-28
CN104436163B (zh) 2017-08-11
RU2012127298A (ru) 2014-01-20
WO2011064384A1 (en) 2011-06-03

Similar Documents

Publication Publication Date Title
MX340231B (es) Enzimas fluidas incubadas y usos de las mismas.
WO2017077329A3 (en) Nucleic acids, peptides and methods
WO2007136679A3 (en) Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
WO2010101742A3 (en) Ampholytic ter-polymers for use in personal care compositions
EA201591281A1 (ru) Рибонуклеиновые кислоты с 4'-тиомодифицированными нуклеотидами и связанные с ними способы
MY155961A (en) Chemical compounds 251
MX2014014902A (es) Composiciones que comprenden apomorfina y acidos organicos y usos de las mismas.
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
BR112013026114A2 (pt) composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas
MX2014007233A (es) Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados.
PL2640352T3 (pl) Hydrolizat kolagenu do zastosowania do poprawy zdrowia ludzkiej skóry, włosów i/lub paznokci
ZA201202705B (en) Peptides used in the treatment and/or care of the skin.mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
BR112014019431A8 (pt) Método compartimentalizado de distribuição de ácido nucleico e composições e usos desses
WO2012019168A3 (en) Engineered nucleic acids and methods of use thereof
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
ATE500265T1 (de) Synthetische mecp2-sequenz für die proteinersatztherapie
MX337575B (es) Compuestos de sulfona y métodos para lafabricación y uso de éstos.
EP3747457A3 (en) Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
BR112015014532A2 (pt) composições cosméticas de fluido de eclosão de peixe
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
WO2009106819A3 (en) Biological materials and uses thereof
IT1405793B1 (it) Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente il gene, e loro uso in terapia genica
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
IT1393841B1 (it) Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi
MY156618A (en) N-acyl amino acid derivatives for treating skin conditions such as cellulite

Legal Events

Date Code Title Description
FG Grant or registration